An Untapped Resource: Pharmacists’ Role in Improving Screening and Management of NVAF

Download All
Experts discuss the role of pharmacists in the screening of nonvalvular atrial fibrillation in 4 microlearning module presentations. Key points about disease burden, screening, management, and adherence are illustrated with a patient case and demonstration of a clinical visit with a patient and pharmacist. Learners can review information with an infographic, podcast, and downloadable slidesets.
Stephanie Dwyer Kaluzna, PharmD, BCCP
Kathleen A. Lusk, PharmD, BCPS, BCCP

ClinicalThought

Cardiology pharmacists’ perspectives on the pharmacist’s role in screening for NVAF, access to DOAC therapies, and dosing nuances.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings